PulseAugur
EN
LIVE 07:31:24

Chinese trial shows gum stem cells improve Type 1 diabetes in over half of patients

By PulseAugur Editorial · [1 sources] ·

A clinical trial in China has shown promising results for treating Type 1 diabetes using stem cells derived from gum tissue. The study, involving participants from Shanghai and Guangzhou, found that over 55% of patients experienced improvements, with one individual no longer requiring external insulin therapy. These findings, based on gingival mesenchymal stem cells (GMSC), were published in the journal Signal Transduction and Targeted Therapy. AI

RANK_REASON The cluster reports on the results of a clinical trial published in a medical journal, which falls under research. [lever_c_demoted from research: ic=1 ai=0.0]

Read on SCMP — Tech →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Chinese trial shows gum stem cells improve Type 1 diabetes in over half of patients

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The cluster reports on the results of a clinical trial published in a medical journal, which falls under research. [lever_c_demoted from research: ic=1 ai=0.0]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
paper, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
Breaking (< 6h)
Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

Full methodology in our editorial standards.

COVERAGE [1]

  1. SCMP — Tech TIER_1 English(EN) · Shi Huang ·

    China trial shows gum tissue stem cells help 55% of lifetime diabetes patients

    A randomised phase 1 clinical trial conducted by scientists and doctors from Shanghai and Guangzhou has achieved encouraging results in the treatment of Type 1 diabetes using stem cells extracted from the mouth’s gum tissue. More than half of those who received the treatment show…

RELATED ENTITIES

RELATED TOPICS